Diet is a modifiable factor associated with the risk of several cancers, with convincing
evidence showing a link between diet and breast cancer. The role of bioactive compounds …

Breast cancer (BC) is the second most common cause of cancer-related deaths in women
throughout the world. Multiple drugs have been approved by US-FDA for breast related …

Breast cancer is the most frequently diagnosed tumor type and the primary leading cause of
cancer deaths in women worldwide and multidrug resistance is the major obstacle for breast …

In an effort to develop new antibacterial drugs, some novel bisindolylmethane derivatives
containing Schiff base moieties were prepared and screened for their antibacterial activity …

Increased abundance of proto-oncogene AKT and reduced expression of tumor suppressor
Forkhead box O3 (FOXO3a), the downstream target of AKT, is frequent in carcinogenesis …

Tumor suppressor retinoblastoma‐associated protein (Rb) is an important cell cycle
regulator, arresting cells in early G1. It is commonly inactivated in cancers and its level is …

The tolerance to adriamycin of cancer as a common and stubborn obstacle occurred during
curing breast cancer patients needs to be overcome. In the present study, we explored …

Emerging evidences suggest abundant expression of Carboxy terminus of Hsc70 Interacting
Protein or CHIP (alias STIP1 Homology and U–box Containing Protein 1 or STUB1) in …

Introduction Nuclear accumulation of β-catenin is important for cancer development and it is
found to overlap with p68 (DDX5) immunoreactivity in most breast cancers, as indicated by …

Current therapy for Glioblastoma is insufficient because of the presence of blood brain
barrier. It limits the transport of essential drugs to the tumor sites. To overcome this limitation …